Lyell Immunopharma, Inc. (LYEL)
25.07
-0.77
(-2.98%)
USD |
NASDAQ |
Jan 23, 16:00
25.07
0.00 (0.00%)
After-Hours: 16:05
Lyell Immunopharma Total Assets (Annual): 490.86M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Insmed, Inc. | 2.025B |
| Nektar Therapeutics | 303.85M |
| GT Biopharma, Inc. | 4.232M |
| Ionis Pharmaceuticals, Inc. | 3.004B |
| Regeneron Pharmaceuticals, Inc. | 37.85B |